Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa Driving Simulator

Annals of Internal Medicine

Volumn 132, Issue 5, 2000, Pages 354-363

  Weiler, John M ^a,b   Bloomfield, John R ^d   Woodworth, George G ^c   Grant, Angela R ^d   Layton, Teresa A ^b   Brown, Timothy L ^e   McKenzie, David R ^f   Baker, Thomas W ^g   Watson, Ginger S ^e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c E11 SSH   (United States)

^d Univ of Iowa Hospitals and Clinics ^*

^e UNIVERSITY OF IOWA   (United States)

^f IQVIA   (United States)

^g Aventis Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DIPHENHYDRAMINE; FEXOFENADINE; PLACEBO; RAGWEED ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISTANCE PERCEPTION; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DROWSINESS; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; SEDATION; SELF REPORT; SIMULATOR; TASK PERFORMANCE; VELOCITY;

EID: 0034090862     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-5-200003070-00004     Document Type: Article

References (33)

1. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99:22-7.
2. Starmer G. Antihistamines and highway safety. Accid Anal Prev. 1985;17: 311-7.
3. Gengo F, Gabos C, Miller JK. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther. 1989;45:15-21.
4. Gengo FM, Gabos C, Mechtler L. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Ann Allergy. 1990;64:520-6.
5. Brookhuis KA, De Vries G, De Waard D. Acute and subchronic effects of the H1-antihistamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance. Br J Clin Pharmacol. 1993;36:67-70.
6. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test a summary of Dutch experience, 1989-94. Allergy. 1995;50:234-42.
7. Cimbura G, Lucas DM, Bennett RC, Warren RA, Simpson HM. Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. J Forensic Sci. 1982;27:855-67.
8. Gengo FM, Manning C. A review of the effects of antihistamines on mental processes related to automobile driving. J Allergy Clin Immunol. 1990;86: 1034-9.
9. Chow SC, Liu JP. Section 5.3 Crossover designs. In: Design and Analysis of Clinical Trials Concept and Methodologies. New York: Wiley; 1998:183-90.
10. Landauer AA, Howat P. Low and moderate alcohol doses, psychomotor performance and perceived drowsiness. Ergonomics. 1983;26:647-57.
11. Kuhl JG, Evans D, Papelis YE, Romano RA, Watson GS. The Iowa Driving Simulator: an immersive research environment. IEEE Computer. 1995;28:35-41.
12. Freeman JS, Watson GS, Papelis YE, Lin TC, Tayyab A, Romano RA, et al. The Iowa Driving Simulator: An Implementation and Application Overview. Warrendale, PA: Soc of Automotive Engineers International, 1995. SAE Technical Paper Series 950174.
13. Witek TJ, Canestrari DA, Miller RD, Yang JY, Riker DK. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists. Ann Allergy Asthma Immunol. 1995;74:419-26.
14. McCormack HM, Home DJ, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988;18:1007-19.
15. Chemik DA, Gilllings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10: 244-51.
16. The MIXED procedure. In: SAS/STAT Software: Changes and Enhancements through Release 6.12. Cary, NC: SAS Institute; 1997:571-702.
17. Weisberg S. Applied Linear Regression. 2d ed. New York: Wiley; 1985.
18. Gelman A, Rubin DB. Markov chain Monte Carlo methods in biostatistics. Stat Methods Med Res. 1996;5:339-55.
19. Spiegelhalter DJ, Thomas A, Best NG. WinBUGS Version 1.2. User Manual. Cambridge, UK: MRC Biostatistics Unit; 1999.
20. The FREQ Procedure, Exact Statistics. In: SAS/STAT Software: Changes and Enhancements through Release 6.12 Cary, NC: SAS Institute; 1997:221-46.
21. Chow SC, Liu JP, eds. Issues in efficacy evaluation In: Design and Analysis of Clinical Trials: Concept and Methodologies. New York: Wiley; 1998:531-2.
22. Gengo FM, Gabos C. Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine. Ann Allergy 1987;59:53-7.
23. Philpot EE, Brooker AE, Biegalski CS. Effects of sedating and nonsedating antihistamines on flying performance. Mil Med. 1993;158:654-60.
24. Vermeeren A, O'Hanlon JF. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol. 1998;101:306-11.
25. Home JA, Baumber CJ. Time-of-day effects of alcohol intake on simulated driving performance in women. Ergonomics. 1991;34:1377-83.
26. Moskowitz H. Validity of driving simulator studies for predicting drug effects in real driving situations. In: Israelstam S, Lambert S, eds. Alcohol, Drugs and Traffic Safety: Proceedings of the Sixth International Conference on Alcohol, Drugs, and Traffic Safety. Toronto: Addiction Research Foundation of Ontario, 1974:295-303.
27. Kerr JS, Hindmarch I. The effects of alcohol alone or in combination with other drugs on information processing, task performance and subjective responses. Human Psychopharmacology 1998;13:1-9.
28. Red Book. Montvale, NJ, Medical Economics; 1998:609.
29. Smith EA. Blame El Niño. Drug Topics. 1998;142:60.
30. Meszaros L. Allergy: old nemesis, new approaches. Managed Healthcare. 1996;6:532-4.
31. Use of OTC antihistamines, NSAIDs saves 12% over brand names. Managed Pharmaceutical Report. 1996,3:7-8.
32. Digest of State Alcohol-Highway Safety Related Legislation. 14th ed. Washington, DC: Office of Alcohol and State Programs, National Highway Traffic Safety Administration, U.S. Department of Transportation; 1996.
33. Slavin RG. Occupational and allergic rhinitis: Impact on worker productivity and safety. Allergy Asthma Proc. 1998;19:277-84.